|
1）Lang IM, Pesavento R, Bonderman D, et al. Risk factors and basic mechanisms of chronic thromboembolic pulmonary hypertension: a current understanding. Eur Respir J. 2013; 41: 462-8
|
|
|
|
2）Sacks RS, Remillard CV, Agange N, et al. Molecular biology of chronic thromboembolic pulmonary hypertension. Semin Thorac Cardiovasc Surg. 2006; 18: 265-76
|
|
|
|
|
|
3）Jamieson SW, Kapelanski DP, Sakakibara N, et al. Pulmonary endarterectomy: experience and lessons learned in 1,500 cases. Ann Thorac Surg. 2003; 76: 1457-62
|
|
|
|
|
|
4）Hosokawa K, Ishibashi-Ueda H, Kishi T, et al. Histopathological multiple recanalized lesion is critical element of outcome after pulmonary thromboendarterectomy. Int Heart J. 2011; 52: 377-81
|
|
|
|
|
5）Yao W, Firth AL, Sacks RS, et al. Identification of putative endothelial progenitor cells (CD34+CD133+Flk-1+) in endarterectomized tissue of patients with chronic thromboembolic pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol. 2009; 296: L870-8
|
|
|
|
|
|
6）Firth AL, Yao W, Ogawa A, et al. Multipotent mesenchymal progenitor cells are present in endarterectomized tissues from patients with chronic thromboembolic pulmonary hypertension. Am J Physiol Cell Physiol. 2010; 298: C1217-25
|
|
|
|
|
|
7）Maruoka M, Sakao S, Kantake M, et al. Characterization of myofibroblasts in chronic thromboembolic pulmonary hypertension. Int J Cardiol. 2012; 159: 119-27
|
|
|
|
|
|
8）Sakao S, Taraseviciene-Stewart L, Lee JD, et al. Initial apoptosis is followed by increased proliferation of apoptosis-resistant endothelial cells. FASEB J. 2005; 19: 1178-80
|
|
|
|
|
|
9）Sakao S, Tatsumi K, Voelkel NF. Endothelial cells and pulmonary arterial hypertension: apoptosis, proliferation, interaction and transdifferentiation. Respir Res. 2009; 10: 95
|
|
|
|
|
|
10）坂尾誠一郎. 慢性血栓塞栓性肺高血圧症成立における血管内皮細胞のアポトーシスについて: 関与の可能性と今後の課題. 分子心血管病. 2008; 9: 361-7
|
|
|
|
|
|
11）Sakao S, Tatsumi K.Crosstalk between endothelial cell and thrombus in chronic thromboembolic pulmonary hypertension: perspective. Histol Histopathol. 2013; 28: 185-93
|
|
|
|
|
|
12）Arciniegas E, Frid MG, Douglas IS, et al. Perspectives on endothelial-to-mesenchymal transition: potential contribution to vascular remodeling in chronic pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol. 2007; 293: L1-8
|
|
|
|
|
|
13）Cool CD, Wood K, Voelkel NF. Transdifferentiation of endothelial cells in primary pulmonary hypertension. Am J Respir Crit Care Resp. 2004; 167: A844
|
|
|
|
|
|
14）Sakao S, Hao H, Tanabe N, et al. Endothelial-like cells in chronic thromboembolic pulmonary hypertension: crosstalk with myofibroblast-like cells. Respir Res. 2011; 12: 109
|
|
|
|
|
|
15）Bonderman D, Turecek PL, Jakowitsch J, et al. High prevalence of elevated clotting factor VIII in chronic thromboembolic pulmonary hypertension. Thromb Haemost. 2003; 90: 372-6
|
|
|
|
|
|
16）Reesink HJ, Meijer RC, Lutter R, et al. Hemodynamic and clinical correlates of endothelin-1 in chronic thromboembolic pulmonary hypertension. Circ J. 2006; 70: 1058-63
|
|
|
|
|
|
17) 水島 昇. オートファジーの生理機能とヒト疾患への関与. 実験医学. 2013; 31: 1374-9
|
|
|
|
|